Contributing to a world free from vaccine preventable diseases.

We increase the access to, and use of, vaccines by supporting public and nonprofit clients in developing better policies, products and tools that strengthen immunisation and disease control programmes.

Our Projects

A world where everyone enjoys a life free from vaccine-preventable diseases.

Explore Our Work

Vaccines are responsible for preventing an estimated 2-3 million deaths per year whilst 1.5 million people worldwide are still dying from vaccine preventable diseases.

Using our public health experience and implementation and academic backgrounds, we assemble the optimal team to ensure that all immunisation programmes are gifted the best chance of success.

Service Offerings

Access

Enable improved access to vaccines and diagnostic products.

Programme Implementation

Support the effective implementation of immunisation and diagnostic programmes.

Policy and Strategy

Strengthen disease control policies and strategies by advising on their development

Evaluation

Conduct evaluations for the productive and beneficial functioning of organisations and activities in the vaccine ecosystem
View All Projects

Learn About Us

Our Story

We support public and non-profit clients in improving the implementation and evaluation of vaccine programmes and products with the end goal of healthier populations, everywhere.

How We Do It

For each project, we assemble the optimal team. Drawing on our worldwide network of experts, we pull together the right blend of skills and knowledge to successfully complete each project.

Our Impact

For each project, we assemble the optimal team. Drawing on our worldwide network of experts, we pull together the right blend of skills and knowledge to successfully complete each project.

Learn More

Team Members in

4 cities

Clients in

16 cities

Research Conducted in

27 countries

Our Clients

Disclaimer: The organisations shown here indicate supplier-client relationships. MMGH has no formal relationship with these organisations nor does this listing indicate any form of endorsement of MMGH’s work beyond the award of past or present contract(s).

Latest Projects

Tuberculosis vaccine market analysis

Evaluate the viability and impact of investment in the clinical development of a new TB vaccine....
View Project

Develop a business case for new treatments for onchocerciasis and lymphatic filariasis

Establishing the business case for investment in new drugs to treat the neglected tropical diseases onchocerciasis and lymphatic filariasis....
View Project

Mid-term evaluation of the European Vaccine Action Plan 2015-2020

Mid-term progress report of the European Vaccine Action Plan 2015-2020....
View Project
View All Projects

For more on our latest projects, Follow us

Follow us on LinkedIn

Latest Publications

As an innovative vaccine delivery technology, vaccine microarray patches could have a meaningful impact on routine immunization coverage in low- and middle-income countries, and vaccine deployment during epidemics and pandemics. This review of the potential use...
Publication
Vaccine
View Publication
Background: Microarray patches (MAPs) are a promising technology being developed to reduce barriers to vaccine delivery based on needles and syringes (N&S). To address the evidence gap on the public health value of applying this potential...
Publication
BMJ Global Health
View Publication
There is growing interest from governments, donors and implementing partners to introduce and scale-up digital health interventions to support immunisation service delivery. A multi-country evaluation was performed with the aim of generating evidence to enable future...
Publication
TechNet-21
View Publication
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 20-22 March 2023. This report summarises the discussions, conclusions and recommendations. It covers the following items: Global Reports Regional reports with deep dive...
Publication
World Health Organisation
View Publication
The global COVID-19 vaccination response provides many lessons on how to better prepare for and respond to future pandemics that require rapid, large-scale vaccination. This document includes a collection of experiences, best practices, and innovations used...
Publication
The COVID-19 Vaccination Response: Country experiences, best practices, and lessons
View Publication
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness...
Publication
World Health Organisation
View Publication
View All Publications

Contact the MMGH Team

Headquarters:

MMGH Consulting GmbH
Kuerbergstrasse 1
8049 Zurich, Switzerland

+41 44 553 04 53

Branch:

MMGH Consulting GmbH
Chemin Maurice-Ravel 11C
1290 Versoix, Switzerland

+41 22 596 78 60

Contact Form